BridgeBio Pharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP | 05/15/2025 | 22.06 M | $762.45 M | -12.20% | 11.60% |
KOHLBERG KRAVIS ROBERTS & CO. L.P. | 05/15/2025 | 19.26 M | $665.85 M | -23.75% | 10.13% |
VANGUARD GROUP INC | 05/09/2025 | 14.90 M | $515.10 M | -1.18% | 7.84% |
BLACKROCK, INC. | 05/02/2025 | 13.36 M | $461.77 M | -2.57% | 7.02% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 7.17 M | $251.73 M | 46.13% | 3.77% |
AISLING CAPITAL MANAGEMENT LP | 05/13/2025 | 6.07 M | $209.78 M | 0.00% | 3.19% |
STATE STREET CORP | 05/15/2025 | 5.75 M | $198.76 M | -7.00% | 3.02% |
FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 5.73 M | $198.12 M | 36.62% | 3.01% |
CAPITAL RESEARCH GLOBAL INVESTORS | 05/12/2025 | 4.67 M | $161.35 M | 32.34% | 2.45% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 3.80 M | $131.38 M | 0.00% | 2.00% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 3.50 M | $121.12 M | 2.49% | 1.84% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 3.11 M | $107.36 M | -11.41% | 1.63% |
LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 2.98 M | $102.96 M | -20.39% | 1.57% |
CITADEL ADVISORS LLC | 05/15/2025 | 2.93 M | $101.33 M | 133.48% | 1.54% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.80 M | $96.80 M | 241.81% | 1.47% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 2.68 M | $92.79 M | -3.94% | 1.41% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 2.22 M | $76.86 M | 9.24% | 1.17% |
INVESCO LTD. | 05/12/2025 | 2.21 M | $76.27 M | 147.02% | 1.16% |
FMR LLC | 05/12/2025 | 2.18 M | $75.22 M | 34.18% | 1.14% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 2.09 M | $72.42 M | 15.65% | 1.10% |
CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 2.00 M | $69.14 M | 25.00% | 1.05% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 1.89 M | $65.26 M | 0.10% | 0.99% |
SC US (TTGP), LTD. | 05/14/2025 | 1.86 M | $64.31 M | 0.00% | 0.98% |
ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 1.85 M | $63.96 M | -6.34% | 0.97% |
WOODLINE PARTNERS LP | 05/15/2025 | 1.63 M | $56.20 M | -26.49% | 0.86% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.50 M | $51.87 M | 100.00% | 0.79% |
MORGAN STANLEY | 05/15/2025 | 1.50 M | $51.81 M | 19.73% | 0.79% |
CITIGROUP INC | 05/12/2025 | 1.40 M | $48.45 M | -8.92% | 0.74% |
NORTHERN TRUST CORP | 05/13/2025 | 1.29 M | $44.49 M | -2.75% | 0.68% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.28 M | $44.33 M | -1.88% | 0.67% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.16 M | $40.27 M | 17.53% | 0.61% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 1.15 M | $39.70 M | 9.35% | 0.60% |
EMERALD ADVISERS, LLC | 05/01/2025 | 1.15 M | $39.60 M | -0.47% | 0.60% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 05/15/2025 | 1.13 M | $39.05 M | 100.00% | 0.59% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 1.12 M | $38.75 M | 4,544.62% | 0.59% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 1.04 M | $36.02 M | 140.59% | 0.55% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 1.03 M | $35.52 M | 1.16% | 0.54% |
05/15/2025 | 962.88 K | $33.29 M | 7.17% | 0.51% | |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 946.85 K | $32.73 M | 117.69% | 0.50% |
PRIMECAP MANAGEMENT CO/CA/ | 05/09/2025 | 913.20 K | $31.57 M | -0.25% | 0.48% |
PFM HEALTH SCIENCES, LP | 05/15/2025 | 908.14 K | $31.39 M | 212.89% | 0.48% |
LORD, ABBETT & CO. LLC | 05/13/2025 | 857.92 K | $29.66 M | 100.00% | 0.45% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 843.32 K | $29.15 M | 253.54% | 0.44% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 800.08 K | $27.66 M | 100.00% | 0.42% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2025 | 769.30 K | $26.59 M | -28.49% | 0.40% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 760.47 K | $26.29 M | 5,856.56% | 0.40% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 739.70 K | $25.57 M | -39.58% | 0.39% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 734.23 K | $25.38 M | 100.00% | 0.39% |
EMERALD MUTUAL FUND ADVISERS TRUST | 05/01/2025 | 724.35 K | $25.04 M | -0.07% | 0.38% |
FIRST TURN MANAGEMENT, LLC | 05/15/2025 | 656.70 K | $22.70 M | 45.19% | 0.35% |
BridgeBio Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 359 institutional investors and hedge funds held shares of BridgeBio Pharma, Inc.. The most heavily invested institutionals were:
VIKING GLOBAL INVESTORS LP: 22.06 M
Kohlberg Kravis Roberts & Co. L.P.: 19.26 M
VANGUARD GROUP INC: 14.9 M
BlackRock, Inc.: 13.36 M
JANUS HENDERSON GROUP PLC: 7.17 M
Aisling Capital Management LP: 6.07 M
97.37% of BridgeBio Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 200.39 M shares in the last 24 months. This purchase volume represents approximately $6.69 B in transactions.